Peptide LedgerEvidence · Safety · Status
Stacked archival regulatory dossiers on a dark walnut desk in warm light

Safety & regulation

Status first. Everything else follows from it.

This is the section we consider most important on the site. Peptides are not one category, and a shared molecule name does not mean shared oversight, quality, or evidence.

The six status categories we use

  • FDA-approved

    A regulator reviewed manufacturing, evidence, and benefit-risk for a defined indication and population. Official labelling exists and post-marketing surveillance applies.

  • Investigational

    Under clinical study with ethics oversight and adverse-event reporting. No approved indication; benefit-risk is not established.

  • Compounded

    Prepared by a pharmacy or outsourcing facility for a specific clinical need. Not premarket-reviewed for safety, efficacy, or manufacturing quality.

  • Research use only

    A commercial label placing material outside medicine regulation. Not evaluated for human administration; purity and sterility are not assured.

  • Cosmetic

    Regulated for topical ingredient safety. No premarket efficacy review; therapeutic claims are not permitted.

  • Preclinical

    Studied only in cells or animals. Human effects, dose, and safety are unknown regardless of how strong the mechanism looks.

Editorial disclaimer

This site is educational and does not provide medical advice, dosing protocols, or treatment recommendations. Regulatory status and evidence strength differ sharply between compounds. A “research use only” label does not indicate that a product is appropriate for human use. Decisions about medicines belong with a qualified clinician.